大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/02/19 | 4,550 | 4,571 | 4,532 | 4,538 | -8 | -0.2% | 925,300 |
2020/02/18 | 4,546 | 4,581 | 4,494 | 4,546 | -56 | -1.2% | 971,900 |
2020/02/17 | 4,598 | 4,628 | 4,565 | 4,602 | -139 | -2.9% | 1,269,300 |
2020/02/14 | 4,892 | 4,984 | 4,726 | 4,741 | -185 | -3.8% | 1,319,500 |
2020/02/13 | 4,880 | 4,939 | 4,858 | 4,926 | -8 | -0.2% | 826,400 |
2020/02/12 | 4,995 | 4,995 | 4,856 | 4,934 | -121 | -2.4% | 831,600 |
2020/02/10 | 5,028 | 5,061 | 4,995 | 5,055 | -37 | -0.7% | 657,600 |
2020/02/07 | 5,140 | 5,158 | 5,079 | 5,092 | -7 | -0.1% | 608,500 |
2020/02/06 | 5,000 | 5,126 | 4,989 | 5,099 | +151 | +3.1% | 1,149,300 |
2020/02/05 | 4,906 | 4,973 | 4,892 | 4,948 | +88 | +1.8% | 699,100 |
2020/02/04 | 4,828 | 4,865 | 4,778 | 4,860 | +10 | +0.2% | 789,800 |
2020/02/03 | 4,870 | 4,886 | 4,824 | 4,850 | -63 | -1.3% | 1,019,400 |
2020/01/31 | 4,924 | 4,987 | 4,904 | 4,913 | +48 | +1% | 801,200 |
2020/01/30 | 4,826 | 4,888 | 4,826 | 4,865 | -10 | -0.2% | 799,900 |
2020/01/29 | 4,844 | 4,875 | 4,801 | 4,875 | +28 | +0.6% | 558,000 |
2020/01/28 | 4,870 | 4,884 | 4,829 | 4,847 | -35 | -0.7% | 649,600 |
2020/01/27 | 4,844 | 4,894 | 4,821 | 4,882 | -71 | -1.4% | 685,300 |
2020/01/24 | 4,954 | 4,971 | 4,918 | 4,953 | +45 | +0.9% | 600,300 |
2020/01/23 | 4,896 | 4,917 | 4,857 | 4,908 | -36 | -0.7% | 563,100 |
2020/01/22 | 4,915 | 4,952 | 4,906 | 4,944 | +23 | +0.5% | 809,800 |
2020/01/21 | 4,916 | 4,954 | 4,908 | 4,921 | -18 | -0.4% | 621,400 |
2020/01/20 | 4,915 | 4,942 | 4,901 | 4,939 | +31 | +0.6% | 459,000 |
2020/01/17 | 4,955 | 4,968 | 4,897 | 4,908 | -71 | -1.4% | 743,300 |
2020/01/16 | 4,978 | 5,000 | 4,954 | 4,979 | +44 | +0.9% | 672,300 |
2020/01/15 | 4,982 | 4,993 | 4,916 | 4,935 | -13 | -0.3% | 598,200 |
2020/01/14 | 4,963 | 4,998 | 4,917 | 4,948 | -46 | -0.9% | 759,700 |
2020/01/10 | 4,955 | 4,994 | 4,923 | 4,994 | +78 | +1.6% | 1,030,400 |
2020/01/09 | 4,870 | 4,922 | 4,865 | 4,916 | +104 | +2.2% | 792,900 |
2020/01/08 | 4,819 | 4,850 | 4,754 | 4,812 | -105 | -2.1% | 1,096,200 |
2020/01/07 | 4,870 | 4,917 | 4,843 | 4,917 | +117 | +2.4% | 1,111,600 |
2020/01/06 | 4,813 | 4,870 | 4,783 | 4,800 | -83 | -1.7% | 995,900 |
2019/12/30 | 4,861 | 4,932 | 4,856 | 4,883 | +14 | +0.3% | 835,000 |
2019/12/27 | 4,911 | 4,911 | 4,850 | 4,869 | -137 | -2.7% | 912,700 |
2019/12/26 | 4,958 | 5,014 | 4,955 | 5,006 | +42 | +0.8% | 803,900 |
2019/12/25 | 5,000 | 5,001 | 4,962 | 4,964 | -30 | -0.6% | 406,900 |
2019/12/24 | 4,982 | 5,020 | 4,977 | 4,994 | +14 | +0.3% | 447,400 |
2019/12/23 | 4,967 | 5,000 | 4,953 | 4,980 | +11 | +0.2% | 480,400 |
2019/12/20 | 4,991 | 5,020 | 4,967 | 4,969 | +8 | +0.2% | 1,724,500 |
2019/12/19 | 4,971 | 5,022 | 4,951 | 4,961 | +9 | +0.2% | 738,500 |
2019/12/18 | 5,053 | 5,072 | 4,945 | 4,952 | -101 | -2% | 1,162,400 |
2019/12/17 | 4,952 | 5,059 | 4,946 | 5,053 | +93 | +1.9% | 1,267,400 |
2019/12/16 | 4,942 | 4,974 | 4,923 | 4,960 | +4 | +0.1% | 745,200 |
2019/12/13 | 4,985 | 4,994 | 4,935 | 4,956 | +72 | +1.5% | 1,732,900 |
2019/12/12 | 4,950 | 4,950 | 4,868 | 4,884 | -53 | -1.1% | 968,200 |
2019/12/11 | 4,910 | 4,949 | 4,881 | 4,937 | +22 | +0.4% | 1,081,700 |
2019/12/10 | 4,908 | 4,930 | 4,891 | 4,915 | +44 | +0.9% | 961,100 |
2019/12/09 | 4,900 | 4,912 | 4,866 | 4,871 | +1 | ±0% | 583,900 |
2019/12/06 | 4,840 | 4,877 | 4,827 | 4,870 | +20 | +0.4% | 606,000 |
2019/12/05 | 4,840 | 4,898 | 4,830 | 4,850 | +36 | +0.7% | 996,800 |
2019/12/04 | 4,778 | 4,830 | 4,771 | 4,814 | -20 | -0.4% | 867,700 |
1351~
1400
件表示中 / 3596件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 789,300円 | +2.2% | +28.0% | 1.77% | 12.63倍 | 1.53倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
武 田 | 440,200円 | -1.1% | +75.3% | 4.54% | 30.49倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 358,800円 | +6.0% | +4.0% | 2.17% | 22.14倍 | 4.09倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
アステラス薬 | 162,900円 | +0.9% | +380.2% | 4.79% | 22.44倍 | 1.93倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 254,000円 | +20.9% | +10.6% | 2.60% | 12.01倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム